Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both.
The management of multiple endocrine neoplasia type 1 (MEN-1) pancreatic-duodenal disease, particularly when the Zollinger-Ellison syndrome (ZES) is the presenting manifestation, has remained controversial. The management of hypoglycaemia and other syndromes as well as large tumours detected by imaging is less controversial, although standardized surgical techniques have not been generally adapted. The rationale for an aggressive operative management plan for ZES and other syndromes is based on the facts that neuroendocrine tumours of both the pancreas and the duodenum have malignant potential and that the functional manifestations can be controlled with appropriate surgical procedures based on current concepts of the MEN-1 disease. Of the ten concepts presented, the one critical to the surgical treatment of ZES is that a duodenotomy is essential in detecting the source of hypergastrinaemia in most MEN-1 patients. The complete operation is multifaceted and includes peripancreatic lymph node dissection (ZES), enucleation of any head or uncinate tumours and a distal pancreatectomy. Our results in 40 MEN-1 patients with functional syndromes treated with these procedures are encouraging. Ten patients with hypoglycaemia (four with concomitant ZES) have been 'cured' with follow-up as long as 18 years. Sixty-eight per cent of 34 patients with ZES have remained eugastrinaemic during follow-up as long as 19 years. One patient developed a solitary liver metastasis that was excised a year ago without other evidence of recurrence. There has been no operative mortality and three subsequent deaths were due to unrelated disease.
Thompson
N W
NW
Division of Endocrine Surgery, University of Michigan, Ann Arbor, USA. normant@umich.edu
D004379:Duodenal Neoplasms / Q000235:genetics / Q000601:surgery*; D005500:Follow-Up Studies; D015408:Gastrinoma / Q000235:genetics / Q000601:surgery*; D006801:Humans; D007003:Hypoglycemia / Q000235:genetics / Q000601:surgery*; D007340:Insulinoma / Q000235:genetics / Q000601:surgery*; D018761:Multiple Endocrine Neoplasia Type 1 / Q000150:complications* / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000601:surgery*; D016019:Survival Analysis; D016896:Treatment Outcome; D015043:Zollinger-Ellison Syndrome / Q000235:genetics / Q000601:surgery*